Abnormal Lung Aging in Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis
The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.
Abstract
Aging is a natural process characterized by progressive functional impairment and reduced capacity to respond appropriately to environmental stimuli and injury. The incidence of two common chronic respiratory diseases (chronic obstructive pulmonary disease [COPD] and idiopathic pulmonary fibrosis [IPF]) increases with advanced age. It is plausible, therefore, that abnormal regulation of the mechanisms of normal aging may contribute to the pathobiology of both COPD and IPF. This review discusses the available evidence supporting a number of aging mechanisms, including oxidative stress, telomere length regulation, cellular and immunosenescence, as well as changes in a number of antiaging molecules and the extracellular matrix, which are abnormal in COPD and/or IPF. A better understanding of these abnormalities may help in the design of novel and better therapeutic interventions for these patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Converging evidence suggests that the aging hallmark, cellular senescence, may be a central mechanism contributing to IPF [6,7].”
From Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study (2019) · cites this paper as [6]
In the citing paper
“IPF pathophysiology is characterized by exaggerated manifestations of the hallmarks of aging in alveolar epithelium and fibroblasts, including cellular senescence.4, 5, 6”
In the citing paper
“A growing body of evidence implicates accelerated mechanisms of ageing, including cellular senescence, in IPF pathogenesis11.”
From Cellular senescence mediates fibrotic pulmonary disease (2017) · cites this paper as [11]
In the citing paper
“cellular senescence has been linked to the pathogenesis of chronic lung diseases such as chronic obstructive pulmonary disease [14, 15] or IPF [16–20].”
From Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo (2017) · cites this paper as [14]
Citations
Cites
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Self-citationRabe, K. F., Hurd, S., Anzueto, A., Barnes, P. J., Buist, S. A., Calverley, P., Fukuchi, Y., Jenkins, C., Rodriguez-Roisin, R., van Weel, C., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200703-456so · Cited by 4,925
The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease
Hogg, J. C., Chu, F., Utokaparch, S., Woods, R., Elliott, W. M., Buzatu, L., Cherniack, R. M., Rogers, R. M., Sciurba, F. C., Coxson, H. O., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032158 · Cited by 3,782
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
Hurst, J. R., Vestbo, J., Anzueto, A., Locantore, N., Müllerova, H., Tal-Singer, R., Miller, B., Lomas, D. A., Agusti, A., MacNee, W., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909883 · Cited by 2,981
Self-citationModulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase
Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D., Jones, D. R., Frye, R. A., & Mayo, M. W. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600244 · Cited by 2,750
Rejuvenation of aged progenitor cells by exposure to a young systemic environment
Conboy, I. M., Conboy, M. J., Wagers, A. J., Girma, E. R., Weissman, I. L., & Rando, T. A. (2005) · Nature · doi:10.1038/nature03260 · Cited by 2,287
Franceschi, C., Capri, M., Monti, D., Giunta, S., Olivieri, F., Sevini, F., Panourgia, M. P., Invidia, L., Celani, L., Scurti, M., et al. (2007) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2006.11.016 · Cited by 2,087
Understanding the odd science of aging
Kirkwood, T. B. L. (2005) · Cell · doi:10.1016/j.cell.2005.01.027 · Cited by 1,984
Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis
Brack, A. S., Conboy, M. J., Roy, S., Lee, M., Kuo, C. J., Keller, C., & Rando, T. A. (2007) · Science · doi:10.1126/science.1144090 · Cited by 1,564
Ortiz, L. A., Gambelli, F., McBride, C., Gaupp, D., Baddoo, M., Kaminski, N., & Phinney, D. G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432929100 · Cited by 1,445
Cited by
Cellular senescence mediates fibrotic pulmonary disease
Schafer, M. J., White, T. A., Iijima, K., Haak, A. J., Ligresti, G., Atkinson, E. J., Oberg, A. L., Birch, J., Salmonowicz, H., Zhu, Y., et al. (2017) · Nature Communications · doi:10.1038/ncomms14532 · Cited by 1,613
Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study
Justice, J. N., Nambiar, A. M., Tchkonia, T., LeBrasseur, N. K., Pascual, R., Hashmi, S. K., Prata, L., Masternak, M. M., Kritchevsky, S. B., Musi, N., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2018.12.052 · Cited by 1,261
“Converging evidence suggests that the aging hallmark, cellular senescence, may be a central mechanism contributing to IPF [6,7].”
BackgroundUpdate on the Pathogenesis of Chronic Obstructive Pulmonary Disease
Agustí, A., & Hogg, J. C. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1900475 · Cited by 551
Self-citationOxidative stress and pulmonary fibrosis
Cheresh, P., Kim, S.-J., Tulasiram, S., & Kamp, D. W. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.11.021 · Cited by 530
“Since this area has been extensively reviewed elsewhere (see for reviews: [1,14,21,46,58,59]), herein we highlight the evidence with asbestos.”
BackgroundInflammation and immunity in IPF pathogenesis and treatment
Heukels, P., Moor, C. C., von der Thüsen, J. H., Wijsenbeek, M. S., & Kool, M. (2019) · Respiratory Medicine · doi:10.1016/j.rmed.2018.12.015 · Cited by 517
New cellular and molecular mechanisms of lung injury and fibrosis in idiopathic pulmonary fibrosis
Fernandez, I. E., & Eickelberg, O. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61144-1 · Cited by 437
Lehmann, M., Korfei, M., Mutze, K., Klee, S., Skronska-Wasek, W., Alsafadi, H. N., Ota, C., Costa, R., Schiller, H. B., Lindner, M., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.02367-2016 · Cited by 403
Meiners, S., Eickelberg, O., & Königshoff, M. (2015) · European Respiratory Journal · doi:10.1183/09031936.00186914 · Cited by 340
Agustí, A., Melén, E., DeMeo, D. L., Breyer-Kohansal, R., & Faner, R. (2022) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00555-5 · Cited by 315
Self-citationChilosi, M., Carloni, A., Rossi, A., & Poletti, V. (2013) · Translational Research · doi:10.1016/j.trsl.2013.06.004 · Cited by 317
Nambiar, A., Kellogg, D., Justice, J., Goros, M., Gelfond, J., Pascual, R., Hashmi, S., Masternak, M., Prata, L., LeBrasseur, N., et al. (2023) · eBioMedicine · doi:10.1016/j.ebiom.2023.104481 · Cited by 298
Chronic obstructive pulmonary disease and comorbidities
Decramer, M., & Janssens, W. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(12)70060-7 · Cited by 291
Chambers, D. C., Enever, D., Ilic, N., Sparks, L., Whitelaw, K., Ayres, J., Yerkovich, S. T., Khalil, D., Atkinson, K. M., & Hopkins, P. M. A. (2014) · Respirology · doi:10.1111/resp.12343 · Cited by 278
Cottin, V., Selman, M., Inoue, Y., Wong, A. W., Corte, T. J., Flaherty, K. R., Han, M. K., Jacob, J., Johannson, K. A., Kitaichi, M., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202206-1041st · Cited by 226
Self-citationCelli, B. R., Decramer, M., Wedzicha, J. A., Wilson, K. C., Agustí, A., Criner, G. J., MacNee, W., Make, B. J., Rennard, S. I., Stockley, R. A., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201501-0044st · Cited by 220
“Such processes may include genetic and epigenetically determined responses (75, 76), an imbalance of proteinases and antiproteinases (76), an abnormal interaction between environment and microbiome (76), alteration of the microbiome (77), a chronic immune response (78), inappropriate control of programmed cell death (…”
BackgroundSelf-citationCelli, B. R., Decramer, M., Wedzicha, J. A., Wilson, K. C., Agustí, A., Criner, G. J., MacNee, W., Make, B. J., Rennard, S. I., Stockley, R. A., et al. (2015) · European Respiratory Journal · doi:10.1183/09031936.00009015 · Cited by 204
Self-citationBustos, M. L., Huleihel, L., Kapetanaki, M. G., Lino-Cardenas, C. L., Mroz, L., Ellis, B. M., McVerry, B. J., Richards, T. J., Kaminski, N., Cerdenes, N., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201306-1043oc · Cited by 190
“reduced capacity to respond appropriately to injury (1, 2).”
BackgroundSelf-citationMitochondria, telomeres and cell senescence: Implications for lung ageing and disease
Birch, J., Barnes, P. J., & Passos, J. F. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.10.005 · Cited by 170
Blue Journal Conference. Aging and Susceptibility to Lung Disease
Thannickal, V. J., Murthy, M., Balch, W. E., Chandel, N. S., Meiners, S., Eickelberg, O., Selman, M., Pardo, A., White, E. S., Levy, B. D., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201410-1876pp · Cited by 166
Lessons from ECLIPSE: a review of COPD biomarkers
Faner, R., Tal-Singer, R., Riley, J. H., Celli, B., Vestbo, J., MacNee, W., Bakke, P., Calverley, P. M. A., Coxson, H., Crim, C., et al. (2014) · Thorax · doi:10.1136/thoraxjnl-2013-204778 · Cited by 160
Self-citationIs Chronic Obstructive Pulmonary Disease an Accelerated Aging Disease?
MacNee, W. (2016) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201602-124aw · Cited by 155
Self-citationRana, T., Jiang, C., Liu, G., Miyata, T., Antony, V., Thannickal, V. J., & Liu, R.-M. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0071oc · Cited by 157
Brandenberger, C., & Mühlfeld, C. (2017) · Cell and Tissue Research · doi:10.1007/s00441-016-2511-x · Cited by 152
The Role of Epithelial Damage in the Pulmonary Immune Response
Burgoyne, R. A., Fisher, A. J., & Borthwick, L. A. (2021) · Cells · doi:10.3390/cells10102763 · Cited by 166
“Cellular senescence is now widely considered an important driving mechanism in several chronic lung diseases including COPD [215], IPF [216,217] and COVID-19 [218,219].”
BackgroundLin, T.-L., Shu, C.-C., Chen, Y.-M., Lu, J.-J., Wu, T.-S., Lai, W.-F., Tzeng, C.-M., Lai, H.-C., & Lu, C.-C. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00554 · Cited by 143
Li, Y., & Yao, H. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13518 · Cited by 148
“Both senescence and inflammatory responses play important roles in the pathogenesis of chronic lung diseases including COPD and lung fibrosis, which we and others have extensively discussed (Aoshiba and Nagai, 2009; MacNee and Tuder, 2009; Faner et al., 2012; Yao and Rahman, 2012a; Yao and Rahman, 2012b; Kumar et al.,…”
BackgroundPan, L., Cheng, Y., Yang, W., Wu, X., Zhu, H., Hu, M., Zhang, Y., & Zhang, M. (2023) · Inflammation · doi:10.1007/s10753-023-01825-2 · Cited by 157
“Oxidative stress (OS), epigenetic alterations, cell aging inflammation, apoptosis, and telomere shortening have been identified as contributing factors to aging and related pulmonary diseases [3].”
Walsh, S. L. F., Mackintosh, J. A., Calandriello, L., Silva, M., Sverzellati, N., Larici, A. R., Humphries, S. M., Lynch, D. A., Jo, H. E., Glaspole, I., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202112-2684oc · Cited by 145
The Impact of Immunosenescence on Pulmonary Disease
Murray, M. A., & Chotirmall, S. H. (2015) · Mediators of Inflammation · doi:10.1155/2015/692546 · Cited by 119
The Role of Mitochondrial DNA in Mediating Alveolar Epithelial Cell Apoptosis and Pulmonary Fibrosis
Kim, S.-J., Cheresh, P., Jablonski, R. P., Williams, D. B., & Kamp, D. W. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160921486 · Cited by 138
“reviewed in detail elsewhere, several lines of evidence demonstrate that ROS play a role in pulmonary fibrotic disease: (1) oxidized lipids and proteins have been identified from the exhaled air, BAL fluid, and lung tissue of patients with fibrotic lung disease [33,34]; and (2) Bleomycin-induced pulmonary fibrosis”
BackgroundCellular Senescence: Pathogenic Mechanisms in Lung Fibrosis
Parimon, T., Hohmann, M. S., & Yao, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126214 · Cited by 135
“However, persistent or accumulation of senescent cells can certainly dysregulate the immune systems and transform the organ microenvironment to favor a chronic inflammatory state that, in part, is commonly observed in many age-related conditions, lung fibrosis included [140-143].”
BackgroundBaek, A.-R., Hong, J., Song, K. S., Jang, A., Kim, D.-J., Chin, S., & Park, S. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00545-z · Cited by 132
Telomere length in circulating leukocytes is associated with lung function and disease
Albrecht, E., Sillanpää, E., Karrasch, S., Alves, A. C., Codd, V., Hovatta, I., Buxton, J. L., Nelson, C. P., Broer, L., Hägg, S., et al. (2014) · European Respiratory Journal · doi:10.1183/09031936.00046213 · Cited by 121
Dynamics of Lung Defense in Pneumonia: Resistance, Resilience, and Remodeling
Quinton, L. J., & Mizgerd, J. P. (2014) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021014-071937 · Cited by 129
“The lungs show signs of aging-induced changes that accelerate with comorbidities (152, 153), which may contribute to pneumonia in the elderly.”
BackgroundCell senescence and fibrotic lung diseases
Liu, R.-M., & Liu, G. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.110836 · Cited by 113
Cellular senescence in the lung across the age spectrum
Parikh, P., Wicher, S., Khandalavala, K., Pabelick, C. M., Britt, R. D., & Prakash, Y. S. (2019) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00424.2018 · Cited by 112
“In the bleomycin mouse model of pulmonary fibrosis, DNA and oxidative damage and have been noted to induce senescence in multiple cell types, including endothelium, fibroblasts, and epithelium (6, 158).”
BackgroundInfluentialAntoniou, K. M., Margaritopoulos, G. A., Goh, N. S. L., Karagiannis, K., Desai, S. R., Nicholson, A. G., Siafakas, N. M., Coghlan, G., Denton, C. P., Hansell, D. M., et al. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39528 · Cited by 111
“Several candidate pathways are common to emphysema and ILD, including oxidative stress (24,25), matrix remodeling (26,27), protein citrullination (28–30), elastin activation (31,32), and telomerase regulation (33).”
BackgroundMitochondrial Dysfunction in Pulmonary Fibrosis
Rangarajan, S., Bernard, K. F., & Thannickal, V. J. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201705-370aw · Cited by 116
Smoking and interstitial lung diseases
Margaritopoulos, G. A., Vasarmidi, E., Jacob, J., Wells, A. U., & Antoniou, K. M. (2015) · European Respiratory Review · doi:10.1183/16000617.0050-2015 · Cited by 115
Senescence-associated secretory phenotype in a mouse model of bleomycin-induced lung injury
Aoshiba, K., Tsuji, T., Kameyama, S., Itoh, M., Semba, S., Yamaguchi, K., & Nakamura, H. (2013) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2013.04.001 · Cited by 100
The Role of Pathological Aging in Cardiac and Pulmonary Fibrosis
Murtha, L. A., Morten, M., Schuliga, M. J., Mabotuwana, N. S., Hardy, S. A., Waters, D. W., Burgess, J. K., Ngo, D. T., Sverdlov, A. L., Knight, D. A., et al. (2019) · Aging and disease · doi:10.14336/ad.2018.0601 · Cited by 96
“cardiovascular disease (CVD) and IPF [37, 39].”
Intracellular C3 Protects Human Airway Epithelial Cells from Stress-associated Cell Death
Kulkarni, H. S., Elvington, M. L., Perng, Y.-C., Liszewski, M. K., Byers, D. E., Farkouh, C. S., Yusen, R. D., Lenschow, D. J., Brody, S. L., & Atkinson, J. P. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0405oc · Cited by 105
Liu, M.-W., Su, M.-X., Tang, D.-Y., Hao, L., Xun, X.-H., & Huang, Y.-Q. (2019) · BMC Pulmonary Medicine · doi:10.1186/s12890-019-0799-5 · Cited by 94
Senescent Cells Contribute to the Physiological Remodeling of Aged Lungs
Calhoun, C., Shivshankar, P., Saker, M., Sloane, L. B., Livi, C. B., Sharp, Z. D., Orihuela, C. J., Adnot, S., White, E. S., Richardson, A., et al. (2016) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glu241 · Cited by 92
“With an increase in the elderly population, more people are being diagnosed with aged-related pulmonary diseases such as chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis (2), and yet the basis/impact of the molecular changes associated with age on the onset and pathology of these diseases is not…”
BackgroundInfluence of age on wound healing and fibrosis
Kapetanaki, M. G., Mora, A. L., & Rojas, M. (2013) · The Journal of Pathology · doi:10.1002/path.4122 · Cited by 90
Self-citationRole of the inflammasome in chronic obstructive pulmonary disease (COPD)
Colarusso, C., Terlizzi, M., Molino, A., Pinto, A., & Sorrentino, R. (2017) · Oncotarget · doi:10.18632/oncotarget.17850 · Cited by 100
“Patients have evidence of oxidative stress in the lungs, blood and skeletal muscle because mitochondrial dysfunctions lead to excessive production of reactive oxygen species (ROS) resulting in harmful effects, as damage to lipids, proteins and DNA [23] (Figure 2).”
BackgroundSmoking accelerates aging of the small airway epithelium
Walters, M. S., De, B. P., Salit, J., Buro-Auriemma, L. J., Wilson, T., Rogalski, A. M., Lief, L., Hackett, N. R., Staudt, M. R., Tilley, A. E., et al. (2014) · Respiratory Research · doi:10.1186/s12931-014-0094-1 · Cited by 87
“Based on the hypothesis that COPD is a disease of accelerated aging [43-46], a number of different studies have analyzed the effect of smoking and COPD status on telomere length in blood leukocytes [6-18].”
Choudhury, G., & MacNee, W. (2016) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412555.2016.1214948 · Cited by 102
“smokers with a dose-dependent relationship between TL and the years smoked, and TL in patients with COPD is shorter than that of control subjects in any age range (81).”
BackgroundSelf-citationInvolvement of GPx4-Regulated Lipid Peroxidation in Idiopathic Pulmonary Fibrosis Pathogenesis
Tsubouchi, K., Araya, J., Yoshida, M., Sakamoto, T., Koumura, T., Minagawa, S., Hara, H., Hosaka, Y., Ichikawa, A., Saito, N., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801232 · Cited by 96
Manevski, M., Muthumalage, T., Devadoss, D., Sundar, I. K., Wang, Q., Singh, K. P., Unwalla, H. J., Chand, H. S., & Rahman, I. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101443 · Cited by 92
“Changes in telomere length reported in former smokers, COPD and IPF patients [192,193].”
BackgroundInfluentialNontypeable Haemophilus influenzae Induces Sustained Lung Oxidative Stress and Protease Expression
King, P. T., Sharma, R., O’Sullivan, K. M., Selemidis, S., Lim, S. C. L., Radhakrishna, N., Lo, C. Y.-W., Prasad, J. D., Callaghan, J. M., McLaughlin, P. J., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120371 · Cited by 82
“Oxidative stress is characterised by the excessive production of reactive oxygen species (ROS) which cause local tissue damage [12, 13].”
BackgroundMartinez, C. H., Díaz, A. A., Meldrum, C. A., Curtis, J. L., Cooper, C. B., Pirozzi, C. S., Kanner, R. E., Paine, R., Woodruff, P. G., Bleecker, E. R., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201604-0871oc · Cited by 86
Cellular Senescence in Lung Fibrosis
Hernandez-Gonzalez, F., Faner, R., Rojas, M., Agustí, A., Serrano, M., & Sellarés, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137012 · Cited by 76
“The pathogenesis of fibrotic lung tissue remodelling is a dynamic orchestrated process and is thought to be strongly linked to aging [4,22].”
BackgroundSelf-citationNeglected evidence in idiopathic pulmonary fibrosis: from history to earlier diagnosis
Cordier, J.-F., & Cottin, V. (2013) · European Respiratory Journal · doi:10.1183/09031936.00027913 · Cited by 78
COPD as a Disease of Immunosenescence
Cho, W., Lee, C. G., & Kim, L. K. (2019) · Yonsei Medical Journal · doi:10.3349/ymj.2019.60.5.407 · Cited by 82
“Intriguingly, the incidence of COPD becomes higher with aging, and peak incidence is observed in patients aged 65–74 years.(4,5) Therefore, aging is considered a critical factor in the development of COPD.”
BackgroundNetwork medicine, multimorbidity and the lung in the elderly
Faner, R., Cruz, T., López-Giraldo, A., & Agustí, A. G. N. (2014) · European Respiratory Journal · doi:10.1183/09031936.00078714 · Cited by 77
Self-citationThe Impact of Tobacco Cigarettes, Vaping Products and Tobacco Heating Products on Oxidative Stress
Emma, R., Caruso, M., Campagna, D., Pulvirenti, R., & Volti, G. L. (2022) · Antioxidants · doi:10.3390/antiox11091829 · Cited by 102
“This is reflected by the elevated levels of oxidative stress markers in COPD patients [47,56,57].”
BackgroundXiao, X., Senavirathna, L. K., Gou, X., Huang, C., Liang, Y., & Liu, L. (2016) · Physiological Reports · doi:10.14814/phy2.12915 · Cited by 71
“The potential risk factors are cigarette smoking (Baumgartner et al. 1997; Raghu et al. 2011), aging (Faner et al. 2012), environmental exposures to metal (brass, lead, and steel) and wood (pine) dusts (Hubbard et al. 1996; Miyake et al. 2005), chronic viral ª 2016 The Authors.”
BackgroundUnderstanding COPD-overlap syndromes
Poh, T. Y., Aogáin, M. M., Chan, A., Yii, A. C. A., Yong, V. F. L., Tiew, P. Y., Koh, M. S., & Chotirmall, S. H. (2017) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2017.1305895 · Cited by 76
“poorly characterized however several factors, common to both diseases, likely play key roles that include smokinginduced oxidative stress [126,127], telomere length abnormalities or mutation [128–135], accelerated cellular and immunosenescence [122], and altered anti-aging molecular and extracellular matrix markers su…”
BackgroundGualtieri, A. F. (2022) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2022.130077 · Cited by 79
“…ROS/RNS production is responsible for the molecular, cellular and tissue abnormalities falling under the um-brella termed “ oxidative stress ” (Faner et al., 2012); 2. release of (transforming or tumour) growth factors like TGF-β , responsible for the growth of epithelial cells; 3. activation…”
miR-34a promotes fibrosis in aged lungs by inducing alveolarepithelial dysfunctions
Cui, H., Ge, J., Xie, N., Banerjee, S., Zhou, Y., Liu, R.-M., Thannickal, V. J., & Liu, G. (2017) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00335.2016 · Cited by 66
“While it is well recognized that IPF is an age-related disease, mostly because a large majority of IPF patients are 50 yr and older (17, 35, 36, 39), much less known is the mechanism involved in the pathogenesis of this disorder in the aged population (15, 40, 42).”
BackgroundRossi, A., Petanjek, B. B., Chilosi, M., Cosío, B. G., Fležar, M., Koulouris, N. G., Marín, J. M., Miculinić, N., Polese, G., Samaržija, M., et al. (2017) · International Journal of COPD · doi:10.2147/copd.s132236 · Cited by 77
Cellular Senescence in Idiopathic Pulmonary Fibrosis
Kellogg, D. L., Kellogg, D. L., Musi, N., & Nambiar, A. M. (2021) · Current Molecular Biology Reports · doi:10.1007/s40610-021-00145-4 · Cited by 67
Aging and Lung Disease. Clinical Impact and Cellular and Molecular Pathways
Rojas, M., Mora, A. L., Kapetanaki, M., Weathington, N., Gladwin, M., & Eickelberg, O. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201508-484pl · Cited by 64
Self-citationAge-Related Changes in the Cellular Composition and Epithelial Organization of the Mouse Trachea
Wansleeben, C., Bowie, E., Hotten, D. F., Yu, Y.-R. A., & Hogan, B. L. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093496 · Cited by 62
“These changes include airspace enlargement, decreased lung compliance, and increased risk for respiratory disorders such as chronic obstructive pulmonary disease (COPD), emphysema, submucosal gland hypertrophy and idiopathic pulmonary fibrosis (IPF), as well as alterations in the innate immune system and lowgrade chro…”
BackgroundCellular Senescence and Senotherapies in the Kidney: Current Evidence and Future Directions
Docherty, M. H., Baird, D., Hughes, J., & Ferenbach, D. A. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00755 · Cited by 69
Telomerase treatment prevents lung profibrotic pathologies associated with physiological aging
Piñeiro-Hermida, S., Autilio, C., Martínez, P., Bosch, F., Pérez-Gil, J., & Blasco, M. A. (2020) · Journal of Cell Biology · doi:10.1083/jcb.202002120 · Cited by 60
Ageing mechanisms that contribute to tissue remodeling in lung disease
Schuliga, M. J., Read, J. M., & Knight, D. A. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101405 · Cited by 65
Luo, J., Hosoki, K., Bacsi, A., Radak, Z., Hegde, M. L., Sur, S., Hazra, T. K., Brasier, A. R., Ba, X., & Boldogh, I. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.03.030 · Cited by 60
Repeated stimulation by LPS promotes the senescence of DPSCs via TLR4/MyD88-NF-κB-p53/p21 signaling
Feng, G., Zheng, K., Cao, T., Zhang, J., Lian, M., Huang, D., Wei, C., Gu, Z., & Feng, X. (2018) · Cytotechnology · doi:10.1007/s10616-017-0180-6 · Cited by 68
“Senescence acts as a physiological or pathological phenomenon, which is characterized by a functional disorder, a decline of homoeostasis, and reduced capacity to respond properly to impair (Faner et al. 2012; Sui et al. 2016).”
BackgroundMechanisms of acute exacerbation of respiratory symptoms in chronic obstructive pulmonary disease
Roca, M., Verduri, A., Corbetta, L., Clini, E., Fabbri, L. M., & Beghé, B. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12064 · Cited by 61
Novel therapeutic strategies for lung disorders associated with airway remodelling and fibrosis
Royce, S. G., Moodley, Y. P., & Samuel, C. S. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.10.008 · Cited by 69
Inflammaging increases susceptibility to cigarette smoke-induced COPD
John-Schuster, G., Günter, S., Hager, K., Conlon, T. M., Eickelberg, O., & Yildirim, A. Ö. (2016) · Oncotarget · doi:10.18632/oncotarget.4027 · Cited by 57
“The resulting anatomic and physiological changes affect both functional organ properties and the ability to mount appropriate responses to infections and injury, thereby leading to an increased incidence of a variety of chronic diseases in the elderly including respiratory diseases such as chronic obstructive pulmonar…”
BackgroundFrengley, J. D., Sansone, G. R., Shakya, K., & Kaner, R. J. (2014) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12597 · Cited by 65
“To compare the effects of diagnoses giving rise to PMV on the likelihood of successful weaning, chronic lung disease was chosen as the reference category because its abnormalities associated with aging are well established.(29,30) Cox proportional hazards regression analysis determined the independent effects of clini…”
MethodOccupational and Environmental Lung Disease
Seaman, D. M., Meyer, C. A., & Kanne, J. P. (2015) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2015.02.008 · Cited by 57
“26).(77) There is a strong association of smoking and IPF.”
BackgroundThe aging lung: tissue telomere shortening in health and disease
Everaerts, S., Lammertyn, E. J., Martens, D. S., Sadeleer, L. D., Maes, K., van Batenburg, A. A., Goldschmeding, R., van Moorsel, C. H. M., Dupont, L., Wuyts, W. A., et al. (2018) · Respiratory Research · doi:10.1186/s12931-018-0794-z · Cited by 57
“Finally, alveolar stem cell exhaustion has been discussed as a key factor in agerelated pulmonary diseases [27, 28].”
BackgroundHermansky–Pudlak syndrome pulmonary fibrosis: a rare inherited interstitial lung disease
Yokoyama, T., & Gochuico, B. R. (2021) · European Respiratory Review · doi:10.1183/16000617.0193-2020 · Cited by 60
The mitochondria in lung fibrosis: friend or foe?
Malsin, E. S., & Kamp, D. W. (2018) · Translational research · doi:10.1016/j.trsl.2018.05.005 · Cited by 58
“SIRT1 decreases in pulmonary macrophages exposed to cigarette smoke and, as such, may have a role in regulating the lung’s long term response to inflammation.(180) Similar to SIRT3, SIRT1 declines with aging and is augmented in the caloric restriction model of longevity.”
BackgroundRoxithromycin attenuates bleomycin-induced pulmonary fibrosis by targeting senescent cells
Zhang, X., Dong, Y., Li, W.-C., Tang, B., Li, J., & Zang, Y. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00618-3 · Cited by 58
Sanei, F., & Wilkinson, T. M. A. (2016) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465816646050 · Cited by 58
“Ageing and immunosenescence The incidence of COPD increases with age, with the highest prevalence of the disease being in individuals over the age of 65 [Faner et al. 2012].”
BackgroundUnfried, K., Krämer, U., Sydlik, U., Autengruber, A., Bilstein, A., Stolz, S., Marini, A., Schikowski, T., Keymel, S., & Krutmann, J. (2016) · International Journal of COPD · doi:10.2147/copd.s115061 · Cited by 56
“Based on clinical observations, COPD can be considered as a phenotype of accelerated lung aging.(4,34,35) Using carbon particles as a model substance for combustion-derived environmental pollution, we recently described that this kind of exposure is in fact able to trigger cellular senescence.”
BackgroundBiomarkers, the control panel and personalized COPD medicine
Agustí, A. G. N., Gea, J., & Faner, R. (2015) · Respirology · doi:10.1111/resp.12585 · Cited by 59
Self-citationIncorporating Biomarkers in COPD Management: The Research Keeps Going
Pantazopoulos, I. N., Magounaki, K., Kotsiou, O. S., Rouka, E. C., Perlikos, F., Kakavas, S., & Gourgoulianis, K. I. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12030379 · Cited by 53
Network Analysis in the Investigation of Chronic Respiratory Diseases. From Basics to Application
Díez, D., Agustí, A. G. N., & Wheelock, C. E. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201403-0421pp · Cited by 53
“…approaches that focus on a single or small number of molecules (e.g., genes or proteins) cannot address this complexity, and integration of high-dimensional data from multiple clinical and biological levels is the new proposed paradigm to elucidate the pathophysiology of pulmonary diseases (2, 3).”
BackgroundSelf-citationOsteoporosis in chronic obstructive pulmonary disease
Romme, E. A., Smeenk, F. W. J. M., Rutten, E. P. A., & Wouters, E. F. �. (2013) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.2013.814402 · Cited by 54
Senescence in Pulmonary Fibrosis: Between Aging and Exposure
Venosa, A. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.606462 · Cited by 54
“This has led to the development of robust genetic models, including the naturally occurring senescence accelerated mouse series (SAM-1 to−8) (52), the telomerase reverse transcriptase (TERT) deficient mice (42, 43), the surfactant protein C mutant and null mice (44, 49), or through disruption of cell-cell communicatio…”
BackgroundBai, Y., Li, J., Zhao, P., Li, Y., Li, M., Feng, S., Qin, Y., Tian, Y., & Zhou, T. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00628 · Cited by 49
“Many studies report that NOX4 is selectively upregulated in lung of PF patients (Faner et al., 2012), and NOX4 inhibitor could attenuate PF in a rodent disease model (Luppi et al.”
BackgroundInfluentialZhang, D., Liu, B., Cao, B., Wei, F., Yu, X., Li, G., Chen, H., Wei, L., & Wang, P.-L. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.04.024 · Cited by 47
“Pulmonary fibrosis, a disease causing considerable morbidity and mortality, is characterized by inflammation, oxidative stress, progressive deposition of collagen and other extracellular matrix (ECM) molecules, which destroy the architecture and function of normal lung tissue [1,2].”
BackgroundRegulation of TERRA on telomeric and mitochondrial functions in IPF pathogenesis
Gao, Y., Zhang, J., Liu, Y., Zhang, S., Wang, Y., Liu, B., Liu, H., Li, R., Lv, C., & Song, X. (2017) · BMC Pulmonary Medicine · doi:10.1186/s12890-017-0516-1 · Cited by 46
“Discussion Many advances enhanced our understanding of IPF pathogenesis and presented substantial evidence supporting several aging mechanisms, including oxidative stress, telomere length regulation, mitochondrial dysfunction, and changes in the number of anti-aging molecules in IPF [27].”
BackgroundSueblinvong, V., Neveu, W. A., Neujahr, D. C., Mills, S. T., Rojas, M., Roman, J., & Guidot, D. M. (2014) · Advances in Bioscience and Biotechnology · doi:10.4236/abb.2014.51004 · Cited by 45
“Aging or “senescence” is associated with increased susceptibility to injury and fibrosis [3-5].”
Self-citationBansode, S. B., & Gacche, R. N. (2019) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2019.08.004 · Cited by 51
Senescence: Pathogenic Driver in Chronic Obstructive Pulmonary Disease
Rivas, M., Gupta, G., Costanzo, L., Ahmed, H., Wyman, A. E., & Geraghty, P. M. (2022) · Medicina · doi:10.3390/medicina58060817 · Cited by 51
“Elevated levels of reactive oxygen species (ROS), low-grade inflammation, shortened telomeres, and an increased number of senescent cells are observed in the aging lung [14].”
BackgroundMolecular and clinical diseasome of comorbidities in exacerbated COPD patients
Faner, R., Gutiérrez-Sacristán, A., Castro-Acosta, A., Grosdidier, S., Gan, W., Sánchez-Mayor, M., Lopez-Campos, J. L., Pozo-Rodriguez, F., Sanz, F., Mannino, D., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.00763-2015 · Cited by 44
Self-citationSilymarin alleviates bleomycin-induced pulmonary toxicity and lipid peroxidation in mice
Razavi-Azarkhiavi, K., Aliomrani, M., Solgi, R., Bagheri, P., Haji-Noormohammadi, M., Amani, N., & Sepand, M. R. (2014) · Pharmaceutical Biology · doi:10.3109/13880209.2014.889176 · Cited by 44
“Oxidative stress consists of cellular and molecular abnormalities caused by overproduction of reactive oxygen species (ROS) as well as reduction in antioxidant defense (Faner et al., 2012; Jones, 2006).”
BackgroundYi, C., Liu, J., Deng, W., Luo, C., Qi, J., Chen, M., & Xu, H. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02731-y · Cited by 48
“The incidence of organ fibrosis, such as pulmonary fibrosis [4], liver cirrhosis [5], renal fibrosis [6], and cardiac fibrosis [7] increases with age.”
BackgroundImmune response in chronic obstructive pulmonary disease
Faner, R., Cruz, T., & Agustí, A. G. N. (2013) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2013.828875 · Cited by 44
Self-citationArafa, M. H., Mohamed, D. A.-E., & Atteia, H. H. (2013) · Environmental Toxicology · doi:10.1002/tox.21891 · Cited by 43
“Lung epithelial cell injury and apoptosis promotes pulmonary fibrosis through limiting normal lung tissue repair (Faner et al., 2012; Noble et al., 2012).”
BackgroundRetractedGazdhar, A., Lebrecht, D., Roth, M., Tamm, M., Venhoff, N., Foocharoen, C., Geiser, T., & Walker, U. A. (2014) · Scientific Reports · doi:10.1038/srep05336 · Cited by 45
“1)* COXI/COXIV-ratio (% of control), mean (SD) 100 (20) 132 (28) 63 (16)* 76 (30) 59 (11)* COXIV/GAPDH-ratio (% of control), mean (SD) 100 (22) 80 (18) 100 (20) 101 (23) 97 (6) www.”
Wu, Z., Zhang, H., Zhou, Z., Li, Z., Liao, S., Wu, Z., Huang, H., & Shi, Y.-C. (2021) · Gland Surgery · doi:10.21037/gs-21-4 · Cited by 46
“Many studies have confirmed that ADSCs can reduce tissue fibrosis, and have certain application values in liver fibrosis, pulmonary fibrosis, and myocardial fibrosis (11-13).”
BackgroundTao, N., Li, K., Liu, J., Fan, G., & Sun, T. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.02.127 · Cited by 42
Metadata
- Authors
- Faner, R., Rojas, M., MacNee, W., & Agustí, A.
- Affiliations
- Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (ES)
- University of Pittsburgh (US)
- The Queen's Medical Research Institute (GB)
- Corresponding author
- Agustí, Alvar
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-08
- Volume
- 186
- Issue
- 4
- Pages
- 306-313
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2160689761
- Cited by
- 268
- References
- 111
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 9 · 2023: 22 · 2022: 18 · 2021: 28 · 2020: 17 · 2019: 26 · 2018: 21 · 2017: 18 · 2016: 15 · 2015: 26 · 2014: 24 · 2013: 26 · 2012: 5
- FWCI
- 20.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- lung aging, chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, oxidative stress, telomere length, cellular senescence, immunosenescence, extracellular matrix, aging mechanisms
- MeSH terms
- Aging, Humans, Inflammation, Lung, Oxidative Stress, Pulmonary Disease, Chronic Obstructive, Idiopathic Pulmonary Fibrosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.